Drawing for Serial No. 75560226

USPTO serial 75560226

Serial No. 75560226

Reviewed by CopyMark Law Group

Reg. 2941020Status 710
Filing date
Status date
Registration date
Apr 19, 2005
Examiner
FAIRBANKS, RONALD L
Law office
POST REGISTRATION

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with Serial No. 75560226?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lawrence E. Abelman

LAWRENCE E ABELMAN ABELMAN FRAYNE & SCHWAB150 E 42ND STNEW YORK, NY 10017-5612UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001Biologically active chemicals, namely, proteins or nucleic acids for use in industry, science, agriculture, horticulture and forestry; chemicals used in industry and science, namely, additives for the storage of potentially pharmaceutically active compounds; reagents and assay kits for biotechnological and chemical research; chemical substances for preserving foodstuffsSECTION 8 - CANCELLED—
005Pharmaceutical preparations for the treatment of disorders of the central nervous system, including neurodegenerative and neuropsychiatric disorders, cancer, obesity, infectious diseases, inflammation, auto-immune diseases and age-related diseases; veterinary preparations for the treatment of disorders of the central nervous system, including but not limited to neurodegenerative and neuropsychiatric disorders, cancer, obesity, infectious diseases, inflammation, auto-immune diseases and age-related diseases; preparations for destroying vermin; fungicides for agricultural or domestic use; herbicides for agricultural or domestic use; reagents and assay kits for medical diagnostics and for the development of pharmaceutical, veterinary and sanitary preparations, of preparations for destroying vermin, and of fungicides and herbicidesSECTION 8 - CANCELLED—
009Scientific apparatus and instruments, namely, optical instruments, namely, microscopes, apparatus for measuring fluorescence, apparatus for measuring light scattering, condensation nucleation particle counter, confocal microscopes, as laboratory equipment for research and industrial use, and for use in the fields of biotechnology, pharmacology, medicine, diagnostics, chemistry and information technology; automated high-throughput apparatus for drug discovery, automated pipeting and dispensing devices in the nature of liquid handling devices, devices for transfer and distribution of liquids, automated devices for handling of sample plates such as microtiter plates or nanotiter plates, devices for trapping dielectric particles, microtiter plates, nanotiter plates, slides, pipettes, dispensers; chromatographic apparatus for the separation of substances in the development and preparation of biotechnological, pharmaceutical and diagnostic products, prerecorded magnetic and optical data carriers featuring computer programs for use in database management, for use as a spreadsheet, for word processing, for use in data management in high-throughput screening, for use in the evaluation and processing of experimental data; computer programs for the evaluation of experimental data in the field of biotechnology, pharmacology, medicine, diagnostics and chemistrySECTION 8 - CANCELLED—
016PRINTED INSTRUCTIONAL MANUALS FOR THE OPERATION AND USE OF BIOTECHNOLOGICAL, PHARMACEUTICAL AND DIAGNOSTIC PRODUCTS; PRINTED INSTRUCTIONAL MANUALS FOR THE OPERATION OF APPARATUS AND DEVICES, NAMELY MICROSCOPES, APPARATUS FOR MEASURING FLUORESCENCE, APPARATUS FOR MEASURING LIGHT SCATTERING, CONDENSATION NUCLEATION PARTICLE COUNTER, CONFOCAL MICROSCOPES, AUTOMATED HIGH THROUGHPUT APPARATUS FOR DRUG DISCOVERY, AUTOMATED PIPETTING AND DISPENSING DEVICES IN THE NATURE OF LIQUID HANDLING DEVICES, DEVICES FOR TRANSFER AND DISTRIBUTION OF LIQUIDS, AUTOMATED DEVICES FOR HANDLING OF SAMPLE PLATES SUCH AS MICROTITER PLATES OR NANOTITER PLATES, DEVICES FOR TRAPPING DIELECTRIC PARTICLES, MICROTITER PLATES, NANOTITER PLATES, SLIDES, PIPETTES, DISPENSERS, CHROMATOGRAPHIC APPARATUSSECTION 8 - CANCELLED—
035Wholesale distributorship featuring biotechnological, pharmaceutical and diagnostic products in the nature of biologically active chemicals, namely, proteins or nucleic acids for use in industry, science, agriculture, horticulture and forestry; chemicals used in industry and science, namely, additives for the storage of potentially pharmaceutically active compounds; reagents and assay kits for biotechnological and chemical research; chemical substances for preserving foodstuffs; pharmaceutical preparations for the treatment of disorders of the central nervous system (including but not limited to neurodegenerative and neuropsychiatric disorders), cancer, obesity, infectious diseases, inflammation, auto-immune diseases and age-related diseases; veterinary preparations for the treatment of disorders of the central nervous system (including but not limited to neurodegenerative and neuropsychiatric disorders), cancer, obesity, infectious diseases, inflammation, auto-immune diseases and age-related diseases; veterinary preparations for the treatment of disorders of the central nervous system (including but not limited to neurodegenerative and neuropsychiatric disorders), cancer, obesity, infectious diseases, inflammation, auto-immune diseases and age-related diseases; preparations for destroying vermin; fungicides for agricultural or domestic use; herbicides for agricultural or domestic use; reagents and assay kits for medical diagnostics and for the development of pharmaceutical, veterinary and sanitary preparations, of preparation for destroying vermin and of fungicides and herbicides; scientific apparatus and instruments, namely optical instruments, automated high-throughput apparatus for drug discovery, automated pipetting and dispensing devices in the nature of liquid handling devices, devices for transfer and distribution of liquids, automated devices for handling of sample plated such as microtiter plates or nanotiter plates, devices for separating biological cells and beads, chromatographic apparatus, devices for trapping dielectric particles, microtiter plates, nanotiter plates, slides, pipettes, dispensers; optical instruments, namely, microscopes, apparatus for measuring fluorescence, apparatus for measuring light scattering, condensation nucleation particles counter, confocal microscopes, as laboratory equipment for research and industrial use, and for use in the fields of biotechnology, pharmacology, medicines, diagnostic, chemistry and information technology; scientific apparatus and instruments, namely, optical instruments, automated high-throughput apparatus for drug discovery, automated pipetting and dispensing devices in the nature of liquid handling devices, devices for transfer and distribution of liquids, automated devices for handling of sample plates such as microtiter plates or nanotiter plates, devices for separating biological cells and beads, chromatographic apparatus, for the development and preparation of biotechnological, pharmaceutical and diagnostic products; prerecorded magnetic and optical data carriers featuring computer programs for use in database management, for use as a spreadsheet, for word processing, for use in data management in high-throughput screening, for use in the evaluation and processing of experimental data; computer programs for the evaluation of experimental data in the field of biotechnology, pharmacology, medicine, diagnostics and chemistry; instructions for useSECTION 8 - CANCELLED—
040Custom manufacture of biotechnological, pharmaceutical and diagnostic products in the nature of biotechnological, pharmaceutical and diagnostic products, namely, biologically active chemicals, namely, proteins or nucleic acids for use in industry, science, agriculture, horticulture and forestry; chemicals used in industry and science, namely, additives for the storage of potentially pharmaceutically active compounds; reagents and assay kits for biotechnological and chemical research; chemical substances for preserving foodstuffs; pharmaceutical preparations for the treatment of disorders of the central nervous system, including but not limited to neurodegenerative and neuropsychiatric disorders, cancer, obesity, infectious diseases, inflammation, auto-immune diseases and age-related diseases; veterinary preparations for the treatment of disorders of the central nervous system (including but not limited to neurodegenerative and neuropsychiatric disorders), cancer, obesity, infectious diseases, inflammation, auto-immune diseases and age-related diseases; preparations for destroying vermin; fungicides for agricultural or domestic use; herbicides for agricultural or domestic use; reagents and assay kits for medical diagnostics and for the development of pharmaceutical, veterinary and sanitary preparations, of preparations for destroying vermin, and of fungicides and herbicides; scientific apparatus and instruments, namely, optical instruments, automated high-throughput apparatus for drug discovery, automated pipetting and dispensing devices in the nature of liquid handling devices, devices for transfer and distribution of liquids, automated devices for handling of sample plates such as microtiter plates or nanotiter plates, devices for separating biological cells and beads, chromatographic apparatus, devices for trapping dielectric particles, microtiter plates, nanotiter plates, slides, pipettes, dispensers; optical instruments, namely, microscopes, apparatus for measuring fluorescence, apparatus for measuring light scattering, condensation nucleation particle counter, confocal microscopes, as laboratory equipment for research and industrial use, and for use in the fields of biotechnology, pharmacology, medicine, diagnostics, chemistry and information technology; scientific apparatus and instruments, namely, optical instruments, automated high-throughput apparatus for drug discovery, automated pipetting and dispensing devices in the nature of liquid handling devices, devices for transfer and distribution of liquids, automated devices for handling of sample plates such as microtiter plates or nanotiter plates, devices for separating biological cells and beads, chromatographic apparatus, devices for trapping dielectric particles, microtiter plates, slides, pipettes and dispensers; optical instruments, namely, microscopes, apparatus for measuring fluorescence, apparatus for measuring light scattering, condensation nucleation particle counter, confocal microscopes, as laboratory equipment for research and industrial use, and for use in the fields of biotechnology, medicines, diagnostics, chemistry and information technologySECTION 8 - CANCELLED—
042Research in the field of biotechnology, pharmacology, medicine, diagnostics, chemistry, information technology, and evolutive methods for others; research and development of new products for others, namely, biotechnological, pharmaceutical and diagnostic products; computer software design for othersSECTION 8 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 21, 2012C8..CANCELLED SEC. 8 (6-YR)—
Nov 25, 2006CORVREVIEW OF CORRESPONDENCE COMPLETE—
Aug 21, 2006MAILPAPER RECEIVED—
Apr 19, 2005R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 25, 2005PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 5, 2005NPUBNOTICE OF PUBLICATION—
Nov 23, 2004PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 23, 2004ALIEASSIGNED TO LIE—
Nov 10, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 27, 2004ACECAMENDMENT FROM APPLICANT ENTERED—
Oct 5, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 5, 2004TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 29, 2004CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 23, 2004ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Feb 27, 2004CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 24, 20031.BDSec. 1(B) CLAIM DELETED—
Oct 24, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 24, 2003MAILPAPER RECEIVED—
Jun 26, 2003CFITCASE FILE IN TICRS—
Jun 9, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 9, 2003MAILPAPER RECEIVED—
May 5, 2003CNSIINQUIRY AS TO SUSPENSION MAILED—
Jun 10, 2002CNSLLETTER OF SUSPENSION MAILED—
Apr 29, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Apr 29, 2002MAILPAPER RECEIVED—
Nov 2, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 20, 2001CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 13, 2000CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Aug 1, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 2, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 24, 1999CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 24, 1999CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 29, 1999DOCKASSIGNED TO EXAMINER—
Apr 28, 1999DOCKASSIGNED TO EXAMINER—

Frequently asked questions

Related guidance